RELATED STORY | FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD Lykos said the issues FDA raised in what's called a complete response letter echoed the concerns ...

Dr. Brian Barnett, a psychiatrist who heads psychedelic research at the Cleveland Clinic in Ohio, also said he thinks MDMA will be eventually approved for PTSD, despite the FDA’s decision.

There are only two FDA-approved treatments for PTSD, and MDMA would be the first to come on the market in decades. Friday's decision comes at a time when there is growing interest in the use of ...

The Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in treating PTSD, and 9-2 against its efficacy. The group cited flawed studies, unclear data and ...

On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD ... from the FDA to Lykos ...

The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known ... durable improvement in their PTSD symptoms,” the FDA wrote in a briefing ...

A key FDA advisory ... with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit and reject the use of what's known as MDMA. Some patients and ...

US regulators rejected the use of Lykos Therapeutics Inc.’s psychedelic drug MDMA for post-traumatic stress ... pressure to approve treatments for PTSD, told the drugmaker that another large ...

“I absolutely agree that we need new and better treatments for PTSD,” Paul Holtzheimer ... An approval by the FDA would mark a major milestone for advocates of MDMA, who contend that ...

A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to ...

Some researchers call MDMA an “empathogen” or a “feeling enhancer.” PTSD affects between 9 million to 13 million people annually in the U.S., and no novel treatments for the condition have been ...

A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment ... encouraging Lykos and the FDA to continue studying psychedelics for PTSD, citing the field’s potential ...